{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T05:40:01Z","timestamp":1654753201246},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1093\/bja\/aex110","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T20:07:46Z","timestamp":1490472466000},"page":"802-804","source":"Crossref","is-referenced-by-count":1,"title":["The diagnostic challenge of a vitamin K antagonist with dabigatran use triggering massive intracranial haemorrhage"],"prefix":"10.1016","volume":"118","author":[{"given":"A.","family":"Pausch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Frossard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wiegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aex110_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"10.1093\/bja\/aex110_bib2","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1161\/CIRCULATIONAHA.115.019628","article-title":"Idarucizumab","volume":"132","author":"Eikelboom","year":"2015","journal-title":"Circulation"},{"key":"10.1093\/bja\/aex110_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijcard.2016.03.056","article-title":"Specific antidotes against direct oral anticoagulants: a comprehensive review of clinical trials data","volume":"214","author":"Tummala","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1093\/bja\/aex110_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(15)60732-2","article-title":"Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial","volume":"386","author":"Glund","year":"2015","journal-title":"Lancet"},{"key":"10.1093\/bja\/aex110_bib5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1345\/aph.1R057","article-title":"Pharmacokinetic and clinical implications of dabigatran use in severe renal impairment for stroke prevention in nonvalvular atrial fibrillation","volume":"46","author":"Mack","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1093\/bja\/aex110_bib6","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1538-7836.2011.04498.x","article-title":"Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial","volume":"9","author":"Liesenfeld","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1093\/bja\/aex110_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1160\/TH14-12-1080","article-title":"A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran","volume":"113","author":"Glund","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1093\/bja\/aex110_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s13181-014-0448-6","article-title":"Enhanced elimination of dabigatran through extracorporeal methods","volume":"11","author":"Awad","year":"2014","journal-title":"J Med Toxicol"},{"key":"10.1093\/bja\/aex110_bib9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1160\/TH11-11-0804","article-title":"Impact of dabigatran on a large panel of routine or specific coagulation assays","volume":"107","author":"Douxfils","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1093\/bja\/aex110_bib10","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1378\/chest.119.1_suppl.8S","article-title":"Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1093\/bja\/aex110_bib11","first-page":"154","article-title":"Influence of dabigatran and rivaroxaban on routine coagulation assays","volume":"113","author":"Van Blerk","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1093\/bja\/aex110_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.thromres.2012.02.014","article-title":"Interpretation and management of INR results: a case history based survey in 13 countries","volume":"130","author":"Kristoffersen","year":"2012","journal-title":"Thromb Res"},{"key":"10.1093\/bja\/aex110_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0035-1546827","article-title":"Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors","volume":"41","author":"Lippi","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 3","key":"10.1093\/bja\/aex110_bib14","doi-asserted-by":"crossref","first-page":"iii18","DOI":"10.1093\/bja\/aew358","article-title":"Perioperative management of the bleeding patient","volume":"117","author":"Ghadimi","year":"2016","journal-title":"Br J Anaesth"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217313454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217313454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/118\/5\/802\/17067388\/aex110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T10:17:54Z","timestamp":1654683474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217313454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0007091217313454"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aex110","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}